La Jolla, CA, United States of America

William C Mobley

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents, primarily in Neurodegenerative Disorders. Top assignees: Neurofluidics, Inc., University of California, Leland Stanford Junior University. Active years: 1992-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William C Mobley. Retrieved from https://idiyas.com/inventor/william-c-mobley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 80.0


 

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 96(Granted Patents)


Location History:

  • Moraga, CA (US) (1992)
  • Palo Alto, CA (US) (2001 - 2015)
  • Stanford, CA (US) (2013 - 2019)
  • La Jolla, CA (US) (2015 - 2021)

Company Filing History:


Years Active: 1992-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cerebrospinal Fluid Purification
Gamma-Secretase Modulators
Neurodegenerative Disorders
Cognitive Function
Alzheimer's Disease
Amyloid Beta Peptides
Neuroprotective Agents
GPR30 Receptor Ligands
Nerve Growth Factor Peptides
Learning Enhancement
Memory Impairment
Down Syndrome
15 patents (USPTO):Explore Patents

Title: The Innovations of William C Mobley

Introduction

William C Mobley, an accomplished inventor based in La Jolla, California, has made substantial contributions to the field of biomedical research. With a remarkable portfolio of 13 patents, his work primarily focuses on addressing neurological disorders, particularly Alzheimer's disease, through innovative solutions.

Latest Patents

Among Mobley's latest patents are two notable inventions that showcase his commitment to advancing medical technology. The first is a patent for "Potent gamma-secretase modulators," which presents compounds and methods aimed at treating disorders associated with abnormal levels of Aβ peptides, including Alzheimer's disease. The second significant invention is a "Cerebrospinal fluid purification system." This patent provides methods and systems for conditioning cerebrospinal fluid (CSF) by effectively removing target compounds. The system is designed for catheter flow paths, allowing a majority volume of CSF to be exchanged in the CSF space. The targeted removal and delivery of specific compounds can be customized to the pathology of various diseases, employing techniques such as size-exclusion thresholds and antibodies against specific toxins.

Career Highlights

Mobley’s career has been marked by fruitful collaborations with prestigious institutions like the University of California and Neurofluidics, Inc. His innovative spirit and extensive research have ventured beyond traditional boundaries, leading to breakthroughs in medical technology.

Collaborations

Throughout his career, Mobley has worked alongside respected colleagues such as Shivanand Lad and Karoly Nikolich. These collaborations have likely enhanced his research capabilities, allowing him to tackle complex challenges in the field of neuroscience.

Conclusion

William C Mobley's contributions to science through his patents and collaborative efforts illustrate a deep commitment to improving healthcare outcomes. His pioneering work continues to inspire future innovations in the realm of neurological research, particularly in the pursuit of solutions for Alzheimer's disease and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…